Skip to main content

Table 3 Enzyme elevations in patients with myocardial infarction identified by the clinical events committee but not the site investigator*

From: Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study

   Median peak CK/ULN   Median peak CK-MB/ULN
Region n (25th, 75th percentiles) n (25th, 75th percentiles)
Eastern Europe 172 0.6 (0.3, 1.2) 167 1.4 (1.2, 1.9)
Latin America 34 0.7 (0.4, 1.2) 34 2.0 (1.3, 2.6)
North America 112 1.6 (1.0, 3.1) 106 2.9 (1.5, 5.5)
Western Europe 202 0.7 (0.4, 2.0) 196 1.7 (1.2, 3.0)
Overall 520 0.9 (0.4, 1.9) 503 1.6 (1.2, 2.9)